HIIFS
JAZZ icon

Harel Insurance Investments & Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-53
Closed -$6K – 403
2016
Q3 		$6K Sell
53
-50
-49% -$6.74K ﹤0.01% 411
2016
Q2 		$15K Buy
103
+20
+24% +$2.95K ﹤0.01% 503
2016
Q1 		$11K Hold
83
– – ﹤0.01% 345
2015
Q4 		$12K Buy
+83
New +$11.5K ﹤0.01% 290

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Harel Insurance Investments & Financial Services's JAZZ Position: Q4 2016 in Review

Harel Insurance Investments & Financial Services sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2016, closing a stake of 53 shares — an estimated $6K sold.

Harel Insurance Investments & Financial Services first reported a position in JAZZ in Q4 2015 and held it in 4 quarters. The position peaked at $15K in Q2 2016. 295 funds tracked by Wall St. Rank hold JAZZ as of Q4 2016.

  • Harel Insurance Investments & Financial Services reported no remaining Jazz Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 53 Jazz Pharmaceuticals shares in Q4 2016, an estimated $6K.
  • Harel Insurance Investments & Financial Services first reported a position in Jazz Pharmaceuticals in Q4 2015 and held it in 4 quarters.
  • Harel Insurance Investments & Financial Services's Jazz Pharmaceuticals position peaked at $15K in Q2 2016.
  • 295 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2016.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2016, filed 6 Feb 2017.